686.20
-3.00
(-0.44%)
As of 1:00:35 PM GMT+2. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 19 | 19 | 23 | 22 |
Avg. Estimate | 2.23B | 2.26B | 9.13B | 9.95B |
Low Estimate | 2.2B | 2.23B | 9.05B | 9.61B |
High Estimate | 2.31B | 2.37B | 9.32B | 10.53B |
Year Ago Sales | 2.13B | 2.16B | 8.75B | 9.13B |
Sales Growth (year/est) | 4.80% | 4.89% | 4.40% | 8.94% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
EQIX.VI | -- | -- | -- | -- |
S&P 500 | 6.79% | 5.59% | 9.06% | 14.11% |
Upgrades & Downgrades
Maintains | Mizuho: Outperform to Outperform | 3/28/2025 |
Maintains | Barclays: Equal-Weight to Equal-Weight | 3/20/2025 |
Maintains | Truist Securities: Buy to Buy | 3/10/2025 |
Maintains | Scotiabank: Sector Outperform to Sector Outperform | 3/3/2025 |
Maintains | Scotiabank: Sector Outperform to Sector Outperform | 2/13/2025 |
Maintains | BMO Capital: Outperform to Outperform | 2/13/2025 |